Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Endocrine Connections|January 16, 2024
The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patientsOrwa Dandash, James Allebone, Adam Mirabelli, et al.
European Journal of Endocrinology|October 22, 2021
Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trialNicholas Russell, Rudolf Hoermann, Ada S Cheung, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 9, 2021
Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trialAda S Cheung, Rudolf Hoermann, Jasmine Zhu, et al.
Clinical Endocrinology|May 26, 2017
Effects of androgen deprivation therapy on telomere lengthAda S Cheung, Bu B Yeap, Rudolf Hoermann, et al.
JCEM Case Reports|May 1, 2026
Development of Graves orbitopathy after thyroidectomy for thyroid cancerMaria Hormiz, Lochlan Sydenham-Clarke, Noor Lammoza, et al.
The Medical Journal of Australia|January 28, 2023
Dual-energy x-ray absorptiometry assessment of bone health in Australian men with prostate cancer commencing androgen deprivation therapyMariya F Hamid, Amy Hayden, Tania Moujaber, et al.
Clinical Endocrinology|February 4, 2014
The prevalence of thyroglossal tract thyroid tissue on SPECT/CT following (131) I ablation therapy after total thyroidectomy for thyroid cancerThomas W Barber, Martin H Cherk, Duncan J Topliss, et al.
The Medical Journal of Australia|March 24, 2011
Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapyMathis Grossmann, Emma J Hamilton, Christopher Gilfillan, et al.
Pageof 20